DST GmbH becomes part of Aesku.Group

AESKU.GROUP acquires DST – Diagnostische Systeme & Technologien GmbH

Wendelsheim & Schwerin, April 2017 – AESKU.GROUP, an innovation leader in autoimmune diagnostics, has acquired the allergy specialists DST Diagnostische Systeme & Technologien GmbH, thereby expanding its product portfolio to include allergy and food intolerance diagnostics.

With this acquisition the competencies of both companies were pooled; as a long-standing and global supplier, AESKU.GROUP has a high level of experience developing, producing and marketing diagnostic assays and automated systems. DST, has a portfolio of over 600 allergens, and proven expertise in allergen production and applications for ELISA, immunoblot and point-of-care (POC) tests. POC tests enable patient-oriented diagnosis without the need for laboratory equipment, being performed directly by Doctors or healthcare practitioners.

In addition to the HELMED® pipetting processor, AESKU.GROUP offers laboratory automation systems that not only process but also read the Tests: SQII (ELISA), HELIA® (BLOT) and HELIOS® (IFA). Since immunoblots are a standard technique in allergy diagnostics, automatic processing of allergy tests by HELIA® will be of great interest in the future.

Dr. Matthias clarified that the integration of DST’s Schwerin–based facility was one of the key strategic milestones in AESKU.GROUP’s expansion. “There is a highly qualified team of employees, with many years of expertise in allergy diagnostics. We are looking forward to future cooperation and are convinced that together we will strengthen and expand our market position.”


AESKU.GROUP, based in Wendelsheim, Germany, offers the most comprehensive product portfolio worldwide in the field of autoimmune diagnostics, with in-house produced kits as well as automated systems. Currently, AESKU.GROUP employs more than 200 people and offers over 150 different products in more than 90 countries all over the world.

AESKU.GROUP is composed of AESKU.DIAGNOSTICS, AESKU.SYSTEMS, AESKU.THERAPY, AESKU.KIPP INSTITUTE and now includes DST GmbH. As a worldwide operating company, AESKU.GROUP has subsidiaries in USA, Singapore and Columbia and a highly developed, world-wide distributor network.

As the first company of AESKU.GROUP, AESKU.DIAGNOSTICS was founded in 2000 by Dr. Torsten Matthias with the aim of simplifying the laboratory routine with accurate, robust and reliable tests. AESKU.GROUPs product portfolio includes not only the AESKULISA®, AESKUSLIDES® & AESKUBLOTS® product lines but also AESQC® quality standards, individual reagents, software solution for laboratory infrastructure (AESKU.LAB) and evaluation as well as device solutions for laboratory automation (HELMED® at the IFA, ELISA or BLOT variant, HELIOS®, HELIA®, SQII). With over 650 installations worldwide, AESKU.GROUPs laboratory solutions are an accepted and established part of the market.

Further information and downloads can be found at: www.aesku.com